Bradford A. Young Joins Pressure BioSciences as Sr. Vice President and Chief Commercial Officer
November 07, 2018 at 10:17 am EST
Share
Pressure BioSciences, Inc. announced that Dr. Bradford A. Young has joined the Company as Sr. Vice President and Chief Commercial Officer ("CCO") effective, November 5, 2018. In this key new leadership position, Dr. Young is responsible for assessing multiple major new and divergent market opportunities, and for optimizing the commercialization priorities and strategy for the Company. Beyond strategic planning, Dr. Young will drive the execution of critical partnering and commercialization programs to build customer adoption and accelerate revenue growth. Prior to joining the Company, Dr. Young provided executive level consulting and leadership roles to biomedical technology, diagnostic and pharmaceutical companies for strategic planning, product development and commercialization.
Pressure BioSciences, Inc. is engaged in providing broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. The Company's enabling platform, Pressure Cycling Technology (PCT), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. The Company's BaroFold technology platform allows it to enter the bio-pharma contract services and GMP manufacturing equipment sector. It has also developed the scalable and pressure-based UltraShear Technology platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be preserved using existing non-thermal technologies.
PRESSURE BIOSCIENCES, INC. 